Patel, Sagar R.
Lerner, Seth P.
Article History
First Online: 15 December 2022
Competing interests
: S.P.L. declares the following competing interests: clinical trials — Endo, FKD, JBL (SWOG), Genentech (SWOG), QED Therapeutics, UroGen, Vaxiion and Viventia; consultant/advisory board — Aura Bioscience, BMS, C2i Genomics, FerGene, Genentech, Pfizer/EMD Serono, Stimit, UroGen, Vaxiion and Verity; patent — TCGA classifier; and honoraria — Annenberg, Clinical Care Options, Grand Rounds Urology, Ology and UroToday. S.R.P. declares no competing interests.